Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001962904 | SCV002232535 | pathogenic | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-11-15 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive spinocerebellar ataxia (PMID: 31103315). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln1519*) in the SYNE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SYNE1 are known to be pathogenic (PMID: 19542096, 24319099, 27086870). ClinVar contains an entry for this variant (Variation ID: 1454968). For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV002246618 | SCV002519836 | pathogenic | Autosomal recessive ataxia, Beauce type | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Solve- |
RCV002246618 | SCV005091483 | likely pathogenic | Autosomal recessive ataxia, Beauce type | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |